Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression

被引:98
作者
Cacev, Tamara [1 ]
Radosevic, Senka [2 ]
Krizanac, Simun [3 ]
Kapitanovic, Sanja [1 ]
机构
[1] Rudjer Boskovic Inst, Div Mol Med, Zagreb 10000, Croatia
[2] PLIVA DD Res & Dev, Zagreb 10000, Croatia
[3] Univ Zagreb, Clin Hosp Dubrava, Zagreb 10000, Croatia
关键词
D O I
10.1093/carcin/bgn164
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytokines produced in the tumour microenvironment have an important role in cancer pathogenesis. Altered cytokine expression may result in increased susceptibility to and/or poor prognosis in certain cancers. Therefore, the aim of this study was to investigate the influence of interleukin (IL)-8 and IL-10 on sporadic colon cancer development and progression. In our study, a statistically significant increase in IL-8 messenger RNA (mRNA) expression and decrease in IL-10 mRNA expression in tumour tissue compared with normal mucous tissue was observed (P = 0.003; P = 1.3 x 10(-9)). No association was found between IL-8 2251 A/T genotypes and IL-8 mRNA expression in tumour and corresponding normal mucous tissue, as well as susceptibility to sporadic colon cancer. Positive immunohistochemical IL-8 staining was more frequent in moderately and poorly differentiated tumours compared with well- differentiated tumours (P = 0.024). Finally, IL-8 significantly stimulated invasion of HT-29 cells in vitro (P = 0.000172). Significant association of IL-10 -1082 A/G, -819 T/C and -592 A/C genotypes and IL-10 mRNA expression in tumour tissue was observed (P = 0.022; P = 0.013; P = 0.02). Significant association of 2819 T/C and 2592 A/C genotypes and IL-10 mRNA expression in corresponding normal mucous tissue was observed (P = 0.01; P = 0.04) as well. IL-10 single-nucleotide polymorphism (SNP) promoter genotypes associated with low IL-10 mRNA expression (2819 TT; 2592 AA) were also associated with increased risk of sporadic colon cancer compared with high-expression genotypes [odds ratio, 5.53; 95% confidence interval (CI), 1.53-20.1; odds ratio, 4.07; 95% CI, 1.28-12.96]. Positive IL-10 immunohistochemical reaction was more frequent in well- differentiated and moderately differentiated tumours compared with poorly differentiated tumours (P = 0.036). In Dukes' C tumours, positive IL-10 immunohistochemical reaction was less frequent compared with Dukes' A and B tumours (P = 0.023). Taken together, our results point to possible tumour promoting role of IL-8 and potential protective role of IL-10 in sporadic colon cancer.
引用
收藏
页码:1572 / 1580
页数:9
相关论文
共 51 条
[41]   FUNCTIONAL-CHARACTERIZATION OF HUMAN IL-10 [J].
SPITS, H ;
MALEFYT, RD .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 99 (01) :8-15
[42]  
Stearns ME, 2003, CLIN CANCER RES, V9, P1191
[43]   Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues [J].
Sugiyama, Y ;
Farrow, B ;
Murillo, C ;
Li, J ;
Watanabe, H ;
Sugiyama, K ;
Evers, BM .
GASTROENTEROLOGY, 2005, 128 (02) :480-486
[44]   SNP discovery in associating genetic variation with human disease phenotypes [J].
Suh, Y ;
Vijg, J .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 573 (1-2) :41-53
[45]   Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer [J].
Theodoropoulos, George ;
Papaconstantinou, Ioannis ;
Felekouras, Evangelos ;
Nikiteas, Nikolaos ;
Karakitsos, Petros ;
Panoussopoulos, Dimitris ;
Lazaris, Andreas Ch ;
Patsouris, Efstratios ;
Bramis, John ;
Gazouli, Maria .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (31) :5037-5043
[46]   An investigation of polymorphism in the interleukin-10 gene promoter [J].
Turner, DM ;
Williams, DM ;
Sankaran, D ;
Lazarus, M ;
Sinnott, PJ ;
Hutchinson, IV .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1997, 24 (01) :1-8
[47]   Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage [J].
Uehara, H ;
Troncoso, P ;
Johnston, D ;
Bucana, CD ;
Dinney, C ;
Dong, ZY ;
Fidler, IJ ;
Pettaway, CA .
PROSTATE, 2005, 64 (01) :40-49
[48]  
Uwatoko N, 2002, INT J ONCOL, V20, P729
[49]   Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer [J].
Veltri, RW ;
Miller, MC ;
Zhao, G ;
Ng, A ;
Marley, GM ;
Wright, GL ;
Vessella, RL ;
Ralph, D .
UROLOGY, 1999, 53 (01) :139-147
[50]   Cancer genes and the pathways they control [J].
Vogelstein, B ;
Kinzler, KW .
NATURE MEDICINE, 2004, 10 (08) :789-799